HeartBeam, Inc.

Equities

BEAT

US42238H1086

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2 ^USD	+1.73%		+3.63%	-14.89%

Apr. 09	HeartBeam, Inc. Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	CI
Mar. 20	Transcript : HeartBeam, Inc., Q4 2023 Earnings Call, Mar 20, 2024

HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

March 20, 2024 at 04:10 pm EDT

HeartBeam, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 14.64 million compared to USD 12.96 million a year ago. Basic loss per share from continuing operations was USD 0.72 compared to USD 1.59 a year ago.

Latest news about HeartBeam, Inc.

HeartBeam, Inc. Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	Apr. 09	CI
Transcript : HeartBeam, Inc., Q4 2023 Earnings Call, Mar 20, 2024	Mar. 20
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
HeartBeam, Inc. Announces First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for Synthesizing A 12-Lead ECG	Mar. 14	CI
HeartBeam, Inc. Receives Two New US Patents for Its Core Cardiac Monitoring Technology	Mar. 07	CI
HeartBeam, Inc. Announces Retirement of Richard Brounstein as Chief Financial Officer	Feb. 05	CI
HeartBeam, Inc. Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights	Dec. 14	CI
Transcript : HeartBeam, Inc., Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
HeartBeam, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Certain Warrants of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2023.	23-10-30	CI
Certain Stock Options of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2023.	23-10-30	CI
Certain Common Stock of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2023.	23-10-30	CI
Heartbeam, Inc. Appoints Richa Gujarati as Senior Vice President, Product	23-09-26	CI
Transcript : HeartBeam, Inc., Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
HeartBeam, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
HeartBeam, Inc. Appoints Michael R. Jaff to the Board of Directors	23-07-26	CI
Heartbeam Appoints Ken Nelson and Mark Strome to the Board of Directors	23-06-08	CI
ADRs End Lower, Numinus Wellness, Heartbeam Trade Actively	23-05-30	DJ
Sector Update: Health Care Stocks Slipping Late Tuesday	23-05-30	MT
Sector Update: Health Care Stocks Lower in Afternoon Trading	23-05-30	MT
HeartBeam Signs New Collaboration Deal With Samsung; Shares Jump	23-05-30	MT
HeartBeam, Inc. Announces Automated Cardiac Detection Patent Granted for Heartbeam Aimigo™ System	23-05-25	CI
HeartBeam Files US FDA Application for HeartBeam AIMIGo System	23-05-18	MT
HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-16	CI

Chart HeartBeam, Inc.

Duration

Period

More charts

Company Profile

HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-09 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2 USD

Average target price

5 USD

Spread / Average Target

+150.00%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
HEARTBEAM, INC.	-14.89%	52.78M
SARTORIUS AG	-11.61%	19.08B
QUIDELORTHO CORPORATION	-46.21%	2.65B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.15%	1.87B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.12%	1.61B
BIOTAGE AB	+22.51%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.69%	1.02B
CONTEC MEDICAL SYSTEMS CO.,LTD	-20.89%	905M
REVENIO GROUP OYJ	-5.74%	716M
VAREX IMAGING CORPORATION	-18.10%	682M

Medical Diagnostic & Testing Equipment